Literature DB >> 23235338

Outbreaks of acute gastroenteritis transmitted by person-to-person contact--United States, 2009-2010.

Mary E Wikswo1, Aron J Hall.   

Abstract

PROBLEM/CONDITION: Approximately 179 million cases of acute gastroenteritis (AGE) occur in the United States each year, and outbreaks of AGE are a substantial public health problem. Although CDC has conducted national surveillance for waterborne and foodborne AGE outbreaks since 1971 and 1973, respectively, no national surveillance existed for AGE outbreaks resulting primarily from person-to-person transmission before implementation of the National Outbreak Reporting System (NORS) in 2009. REPORTING PERIOD: 2009-2010. DESCRIPTION OF SYSTEM: NORS is a national surveillance system launched in 2009 to support the reporting of all waterborne outbreaks and enteric disease outbreaks from foodborne, person-to-person, animal contact, environmental, and unknown modes of transmission. State and local public health agencies in the 50 U.S. states, the District of Columbia, five U.S. territories, and three Freely Associated States report these outbreaks to CDC via NORS using a standardized online data entry system. Data are collected on general outbreak characteristics (e.g., dates, number of illnesses, and locations), demographic characteristics of cases (e.g., age and sex), symptoms, case outcomes, and laboratory testing information and results. Only outbreaks reported in NORS with a primary mode of transmission of person-to-person contact are included in this report.
RESULTS: During 2009-2010, a total of 2,259 person-to-person AGE outbreaks were reported in NORS from 42 states and the District of Columbia. These outbreaks resulted in 81,491 reported illnesses, 1,339 hospitalizations, and 136 deaths. No etiology was reported in approximately 40% (n = 840) of outbreaks. Of the remaining 1,419 outbreaks with a reported etiology, 1,270 (89%) were either suspected or confirmed to be caused solely by norovirus. Other reported etiologies included Shigella (n = 86), Salmonella (n = 16), Shiga toxin-producing Escherichia coli (STEC) (n = 11), and rotavirus (n = 10). Most (82%) of the 1,723 outbreaks caused by norovirus or an unknown etiology occurred during the winter months, and outbreaks caused by Shigella or another suspected or confirmed etiology most often occurred during the spring or summer months (62%, N = 53 and 60%, N = 38, respectively). A setting was reported for 1,187 (53%) of total outbreaks. Among these reported settings, nursing homes and other long-term-care facilities were most common (80%), followed by childcare centers (6%), hospitals (5%), and schools (5%).
INTERPRETATION: NORS provides the first national data on AGE outbreaks spread primarily through person-to-person transmission and describes the frequency of this mode of transmission. Norovirus is the most commonly reported cause of these outbreaks and, on the basis of epidemiologic characteristics, likely accounts for a substantial portion of the reported outbreaks of unknown etiology. In the United States, sporadic and outbreak-associated norovirus causes an estimated 800 deaths and 70,000 hospitalizations annually, which could increase by an additional 50% during epidemic years. During 2009-2010, norovirus outbreaks accounted for the majority of deaths and health-care visits in person-to-person AGE outbreaks reported to NORS. PUBLIC HEALTH ACTION: Prevention and control of person-to-person AGE outbreaks depend primarily on appropriate hand hygiene and isolation of ill persons. NORS surveillance data can help identify the etiologic agents, settings, and populations most often involved in AGE outbreaks resulting primarily from person-to-person transmission and guide development of targeted interventions to avert these outbreaks or mitigate the spread of infection. Surveillance for person-to-person AGE outbreaks via NORS also might be important in clarifying the epidemiology and role of certain pathogens (e.g., STEC) that have been traditionally considered foodborne but can also be transmitted person-to-person. As ongoing improvements and enhancements to NORS are introduced, participation in NORS has the potential to increase, allowing for improved estimation of epidemic person-to-person AGE and its relative importance among other modes of transmission.

Entities:  

Mesh:

Year:  2012        PMID: 23235338

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  38 in total

1.  Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Authors:  BreOnna C DeLaine; Tao Wu; Christen L Grassel; Avital Shimanovich; Marcela F Pasetti; Myron M Levine; Eileen M Barry
Journal:  Pathog Dis       Date:  2016-04-21       Impact factor: 3.166

Review 2.  Multiplex polymerase chain reaction tests for detection of pathogens associated with gastroenteritis.

Authors:  Hongwei Zhang; Scott Morrison; Yi-Wei Tang
Journal:  Clin Lab Med       Date:  2015-04-04       Impact factor: 1.935

Review 3.  Small Intestinal Infections.

Authors:  Khushboo Munot; Donald P Kotler
Journal:  Curr Gastroenterol Rep       Date:  2016-06

4.  Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children.

Authors:  Maribeth R Nicholson; Gerald T Van Horn; Yi-Wei Tang; Jan Vinjé; Daniel C Payne; Kathryn M Edwards; James D Chappell
Journal:  J Pediatr       Date:  2016-06-18       Impact factor: 4.406

5.  Epidemiology and molecular characteristics of norovirus GII.4 Sydney outbreaks in Taiwan, January 2012-December 2013.

Authors:  Fang-Tzy Wu; Hsieh-Cheng Chen; Catherine Yen; Ching-Yi Wu; Kazuhiko Katayama; YoungBin Park; Aron J Hall; Jan Vinjé; Jason C Huang; Ho-Sheng Wu
Journal:  J Med Virol       Date:  2015-05-06       Impact factor: 2.327

Review 6.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

7.  Emergence of a novel GII.17 norovirus – End of the GII.4 era?

Authors:  M de Graaf; J van Beek; H Vennema; A T Podkolzin; J Hewitt; F Bucardo; K Templeton; J Mans; J Nordgren; G Reuter; M Lynch; L D Rasmussen; N Iritani; M C Chan; V Martella; K Ambert-Balay; J Vinjé; P A White; M P Koopmans
Journal:  Euro Surveill       Date:  2015-07-02

8.  Potential of Pulsed Light to Inactivate Bacteriophage MS2 in Simple Liquid Medium and on Complex Foodstuffs.

Authors:  Gaël Belliot; Julie Loutreul; Marie Estienney; Catherine Cazeaux; Irina Nicorescu; Serge Aho; Patrick Gervais; Nicole Orange; Pierre Pothier; Thierry Morin
Journal:  Food Environ Virol       Date:  2013-03-23       Impact factor: 2.778

Review 9.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

10.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.